Т. А. Кармакова

617 total citations
38 papers, 486 citations indexed

About

Т. А. Кармакова is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Т. А. Кармакова has authored 38 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 14 papers in Biomedical Engineering and 13 papers in Molecular Biology. Recurrent topics in Т. А. Кармакова's work include Photodynamic Therapy Research Studies (15 papers), Nanoplatforms for cancer theranostics (14 papers) and Porphyrin and Phthalocyanine Chemistry (8 papers). Т. А. Кармакова is often cited by papers focused on Photodynamic Therapy Research Studies (15 papers), Nanoplatforms for cancer theranostics (14 papers) and Porphyrin and Phthalocyanine Chemistry (8 papers). Т. А. Кармакова collaborates with scholars based in Russia, France and Spain. Т. А. Кармакова's co-authors include R. I. Yakubovskaya, Alexey V. Feofanov, Paul Vigny, А. Ф. Миронов, Alexeï Grichine, Marguerite Egret-Charlier, А. Д. Каприн, Н. С. Сергеева, B. Yа. Alekseev and Jean‐Claude Maurizot and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Biophysical Journal.

In The Last Decade

Т. А. Кармакова

35 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Т. А. Кармакова Russia 14 240 200 174 150 65 38 486
Hongwei Guan China 14 84 0.3× 32 0.2× 121 0.7× 315 2.1× 25 0.4× 35 655
Kazuko Matsumoto Japan 14 62 0.3× 97 0.5× 136 0.8× 304 2.0× 53 0.8× 25 502
Tatyana S. Godovikova Russia 15 37 0.2× 53 0.3× 100 0.6× 409 2.7× 72 1.1× 46 745
Wakako Hiraoka Japan 12 107 0.4× 170 0.8× 110 0.6× 248 1.7× 22 0.3× 33 554
Hiroaki Akasaka Japan 16 233 1.0× 201 1.0× 103 0.6× 102 0.7× 92 1.4× 43 565
Tanaya R. Vaidya United States 7 60 0.3× 53 0.3× 40 0.2× 158 1.1× 28 0.4× 17 439
Panayiotis A. Scourides Australia 10 285 1.2× 130 0.7× 211 1.2× 154 1.0× 26 0.4× 13 416
R. Ouellet Canada 13 193 0.8× 173 0.9× 182 1.0× 153 1.0× 26 0.4× 29 538
Stein Sommer Norway 12 623 2.6× 360 1.8× 379 2.2× 281 1.9× 38 0.6× 16 790
Cesare Achilli Italy 15 167 0.7× 49 0.2× 80 0.5× 217 1.4× 60 0.9× 25 576

Countries citing papers authored by Т. А. Кармакова

Since Specialization
Citations

This map shows the geographic impact of Т. А. Кармакова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Т. А. Кармакова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Т. А. Кармакова more than expected).

Fields of papers citing papers by Т. А. Кармакова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Т. А. Кармакова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Т. А. Кармакова. The network helps show where Т. А. Кармакова may publish in the future.

Co-authorship network of co-authors of Т. А. Кармакова

This figure shows the co-authorship network connecting the top 25 collaborators of Т. А. Кармакова. A scholar is included among the top collaborators of Т. А. Кармакова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Т. А. Кармакова. Т. А. Кармакова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Кармакова, Т. А., et al.. (2023). Predictive significance of HIF-1α, Snail, and PD-L1 expression in breast cancer. Clinical and Experimental Medicine. 23(6). 2369–2383. 3 indexed citations
3.
4.
Сергеева, Н. С., et al.. (2022). Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part I. Tumor-Promoting Inflammation. Serum Inflammatory Markers. Annals of the Russian academy of medical sciences. 77(5). 345–353. 1 indexed citations
5.
Кармакова, Т. А., et al.. (2021). Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review). Sovremennye tehnologii v medicine. 13(3). 64–64. 62 indexed citations
6.
Сергеева, Н. С., et al.. (2020). KIM-1 (kidney injury molecule 1) in the urine of renal cell carcinoma patients. SHILAP Revista de lepidopterología. 16(3). 21–28. 2 indexed citations
7.
Кармакова, Т. А., et al.. (2020). Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile. Translational Oncology. 13(4). 100762–100762. 11 indexed citations
8.
Сергеева, Н. С., et al.. (2020). CLINICAL SIGNIFICANSE OF PROSTATE-SPECIFIC ANTIGEN IN BREAST CANCER PATIENTS. SHILAP Revista de lepidopterología. 19(6). 28–37. 1 indexed citations
9.
Ryabova, A. V., et al.. (2020). The research of chlorine e6 distribution and accumulation in multicellular tumor spheroid model. Optical and Quantum Electronics. 52(2). 1 indexed citations
10.
Кармакова, Т. А., et al.. (2018). Subcutaneous and orthotopic xenograft models of human bladder carcinoma in nude mice for epidermal growth factor receptor-targeted treatment. Russian Journal of Biotherapy. 17(2). 31–40.
11.
Rosenkranz, Andrey A., Tatiana A. Slastnikova, Т. А. Кармакова, et al.. (2018). Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression. Frontiers in Pharmacology. 9. 1331–1331. 36 indexed citations
12.
Kim, Yan, et al.. (2010). Antibodies to synthetic peptides for the detection of survivin in tumor tissues. Russian Journal of Bioorganic Chemistry. 36(2). 164–171. 4 indexed citations
13.
Ignatova, Anastasia A., Alexey V. Feofanov, Т. А. Кармакова, et al.. (2007). 13,15-N-Cycloimide derivatives of chlorin p6 with isonicotinyl substituent are photosensitizers targeted to lysosomes. Photochemical & Photobiological Sciences. 6(11). 1184–1196. 21 indexed citations
14.
Шаронов, Г. В., Т. А. Кармакова, Matthieu Réfrégiers, et al.. (2005). Cycloimide bacteriochlorin p derivatives: Photodynamic properties and cellular and tissue distribution. Free Radical Biology and Medicine. 40(3). 407–419. 25 indexed citations
15.
Кармакова, Т. А., Alexey V. Feofanov, R. I. Yakubovskaya, et al.. (2005). Tissue distribution and in vivo photosensitizing activity of 13,15-[N-(3-hydroxypropyl)]cycloimide chlorin p6 and 13,15-(N-methoxy)cycloimide chlorin p6 methyl ester. Journal of Photochemistry and Photobiology B Biology. 82(1). 28–36. 17 indexed citations
16.
Feofanov, Alexey V., Alexeï Grichine, Т. А. Кармакова, et al.. (2002). Near-infrared Photosensitizer Based on a Cycloimide Derivative of Chlorin p6: 13,15-N-(3′-Hydroxypropyl)Cycloimide Chlorin p6¶. Photochemistry and Photobiology. 75(6). 633–633. 39 indexed citations
17.
Gladysheva, Inna P., Т. А. Кармакова, R. I. Yakubovskaya, et al.. (2001). Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman–Birk soybean proteinase inhibitor. Journal of Controlled Release. 74(1-3). 303–308. 4 indexed citations
18.
Gladysheva, Inna P., et al.. (2001). Immunoconjugates of Soybean Bowman-Birk Protease Inhibitor as Targeted Antitumor Polymeric Agents. Journal of drug targeting. 9(5). 303–316. 13 indexed citations
19.
Feofanov, Alexey V., Alexeï Grichine, Т. А. Кармакова, et al.. (2000). Confocal Raman Microspectroscopy and Imaging Study of Theraphthal in Living Cancer Cells. Biophysical Journal. 78(1). 499–512. 66 indexed citations
20.
Feofanov, Alexey V., et al.. (1999). [Study of localization and molecular interactions of biologically active compounds in living cells and tissue slices based on confocal microspectroscopy and reconstruction of the spectral images].. PubMed. 25(12). 892–902. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongwei Guan Breakdown of academic impact, for papers by Kazuko Matsumoto Breakdown of academic impact, for papers by Tatyana S. Godovikova Breakdown of academic impact, for papers by Wakako Hiraoka Breakdown of academic impact, for papers by Hiroaki Akasaka Breakdown of academic impact, for papers by Tanaya R. Vaidya Breakdown of academic impact, for papers by Panayiotis A. Scourides Breakdown of academic impact, for papers by R. Ouellet Breakdown of academic impact, for papers by Stein Sommer Breakdown of academic impact, for papers by Cesare Achilli
Rankless by CCL
2026